XenoPort, Glaxo end collaboration on restless legs syndrome drug – Yahoo!7 News

by admin on November 10, 2012


Yahoo!7 News
XenoPort, Glaxo end collaboration on restless legs syndrome drug
Yahoo!7 News
(Reuters) – XenoPort Inc said it agreed with its marketing partner GlaxoSmithKline to end their collaboration on Horizant, a drug to treat restless legs syndrome. Glaxo will return all rights to the drug to XenoPort by April 30 and buy $20 million

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: